Reaction
Lipodystrophy Acquired reporting signals
As of the last recalculation, Lipodystrophy Acquired appears in 2,106 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is ZIDOVUDINE (PRR 406.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Zidovudine | 436 | 406.1 | 419.9 |
| Nevirapine | 314 | 404.1 | 418.7 |
| Abacavir Sulfate | 286 | 335.6 | 345.8 |
| Lopinavir And Ritonavir | 291 | 246.0 | 251.5 |
| Lamivudine Oral | 476 | 240.0 | 244.6 |
| Lamivudine | 552 | 238.9 | 243.3 |
| Efavirenz | 230 | 228.8 | 233.6 |
| Ritonavir | 460 | 198.8 | 202.0 |
| Ritonavir 100 Mg | 263 | 198.7 | 202.2 |
| Atazanavir | 236 | 182.7 | 185.7 |
| Darunavir | 244 | 180.2 | 183.2 |
| Raltegravir | 217 | 144.7 | 146.6 |
| Tenofovir Disoproxil Fumarate Tablets | 105 | 126.4 | 128.0 |
| Tenofovir Disoproxil Fumarate | 277 | 95.2 | 96.0 |
| Asfotase Alfa | 81 | 83.1 | 83.7 |
| Dolutegravir Sodium | 34 | 37.8 | 38.0 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 137 | 31.7 | 31.8 |
| Glatiramer Acetate | 95 | 16.4 | 16.4 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 15 | 14.8 | 14.9 |
| Emtricitabine And Tenofovir Alafenamide | 14 | 12.3 | 12.3 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 8 | 8.8 | 8.8 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 16 | 8.8 | 8.8 |
| Insulin Glulisine | 7 | 6.8 | 6.8 |
| Insulin Degludec | 11 | 4.7 | 4.7 |
| Interferon Beta-1B | 7 | 3.6 | 3.6 |
| Somatropin | 18 | 2.4 | 2.4 |